Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Neoplasms × domatinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 2 Carcinoma, Merkel Cell 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Oxaliplatin 25 Fluorouracil 22 Leucovorin 19 Surveys and Questionnaires 16 Irinotecan 15 Capecitabine 15 Bevacizumab 12 Cisplatin 11 Drug Therapy 10 Gemcitabine 9 Standard of Care 8 Nivolumab 8 Blood Specimen Collection 8 S 1 (combination) 6 Endoscopic Mucosal Resection 6 Cetuximab 6 pembrolizumab 5 atezolizumab 5 Sunitinib 5 Educational Status 5 Cyclophosphamide 5 Radiotherapy 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Interviews as Topic 4 Folfox protocol 4 Everolimus 4 Docetaxel 4 130-nm albumin-bound paclitaxel 4 tegafur-gimeracil-oteracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03812796 2019-02-05

EMERGE

Royal Marsden NHS Foundation Trust

Phase 2 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡